• Home
  • Textbook
  • Course
  • WDSCF
  • SNOPs
  • About
  • Questions

Neuropathology

Module Overview

This module covers the core of neuropathology. We parse these topics into AlzD vs. Other Dementias (combining the molecular and clinical stories). Thus, the two Slide Sets for this chapter are designated Chapter12-13: Part-1 and Chapter12-13: Part-2. Part-1 is for non-AlzD dementias (LBD and FTD mainly), while Part-2 is for AlzD. THIS PARSING might seem a bit odd, but the Chapters read better as parsed and the lectures/slide sets provide a complementary and reinforcing approach to the complexities of Neurodegenerative Disease!
  • Chapter 12 focuses on molecular pathology
  • Chapter 13 focuses on clinical aspects of neuropathology
  • Chapter 14 covers the potentially crucial yet fuzzy topic of Cognitive Reserve (slideset not available)
  • Chapter 15 has an assortment of deep dives into the neural system issues associated with several dementias (slideset not available)
gallery

Slidesets

Molecular NBOA - Dementias Galore (Ch 12-13 part 1)
Chapters 12-13 Part 1 Reviews clinical aspects of dementia - notably cognitive symptoms, differential diagnosis, treatments, and prognosis. Covers time course, progression, and imaging details of most prevalent non-AlzD neurodegenerative disorders (Lewy Body disease, Parkinson's, frontotemporal dementia). Includes cellular processes that may give rise to pathology, pernicious RNA-binding protiens, protein aggregates, and other microscoping pathological processes.
Molecular NBOA - Alzheimer's Disease (Ch 12-13 Part 2)
Chapters 12-13 Part 2 Explores the molecular core and clinical aspects if Alzheimer's Disease specifically. This involves cellular processes that may give rise to pathology including those involved in the dementias of part 1, as well as ApoE, dystrophic neurites, and transport, catabolism, concomitant protein aggregation, and disruption of normal neuronal operations. The prion-like spread of neurotoxic proteins along fiber bundles is also considered and ties into the tau-amyloid debate of the last 20 years, which is perhaps beginning to resolve as evidence grows in favor of a causal sequence.

Additional Resources

HOT OFF THE PRESS: An Article and Commentary were just published in Neuron (March 3rd, 2021) which provide a perfect dive into the heart of the Neurodegenerative Problem! [Many thanks to the student who shared this new article with me!]. Because this article provides such elemental, explanatory and timely info, both articles should be read and we will discuss them in our coursework. We will focus on these in an upcoming lecture after covering some Chapter 12 basics.
  • Targeting Pre-Synaptic Tau Accumulation: A New Strategy to Counteract Tau-Mediated Synaptic Loss and Memory Deficits - Holtzman & Gratuze, 2021
  • Lowering Synaptogyrin-3 Expression Rescues Tau-Induced Memory Defects and Synaptic Loss in the Presence of Microglial Activation - Barrientos et. al, 2021

  • Effect of Cognitive Prehabilitation on the Incidence of Postoperative Delirium Among Older Adults Undergoing Major Noncardiac Surgery - Humeiden et. al, 2020
  • Amyloid-beta Oligomers in Alzheimer's Disease Pathogenesis, Treatment, and Diagnosis - Klein & Viola, 2015
  • Efficiency, Capacity, Compensation, Maintenance, Plasticity: Emerging Concepts in Cognitive Reserve - Barulli & Stern, 2013
  • Primary Progressive Aphasia: A Model for Neurodegenerative Disease - Gorno-Tempini & Tee, 2019
  • A Task-Invariant Cognitive Reserve Network - Stern et. al, 2018
Copyright © 2020 Donald M. O'Malley -- except for Template Images which belong to Web.com I reckon!

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories

Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.